Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Other Non-Current Assets came in at $294.0 million in Q2 2026, down 3.61% YoY from $305.0 million in Q2 2025, and down 2.65% on a QoQ basis from $302.0 million in Q1 2026.
Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Other Non-Current Assets data on file, last reported at $294.0 million in Q2 2026.
- Quarterly Other Non-Current Assets fell 3.61% year-over-year to $294.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $294.0 million (down 3.61% YoY) and the FY2025 annual result came in at $310.0 million, up 5.44% from the prior year.
- Other Non-Current Assets retreated to $294.0 million in Q2 2026, from $302.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $310.0 million in Q3 2024 to a low of $188.0 million in Q1 2022.
- A 5-year average of $255.7 million and a median of $240.0 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets dropped 7.02% — and 2024, when it soared 46.23%.
- Tracing BLCO's Other Non-Current Assets over 5 years: stood at $215.0 million in 2022, then grew by 4.65% to $225.0 million in 2023, then surged by 30.67% to $294.0 million in 2024, then rose by 5.44% to $310.0 million in 2025, then decreased by 5.16% to $294.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $294.0 million (Q2 2026), $302.0 million (Q1 2026), and $310.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 294.00 Mn |
| Mar 31, 2026 | 302.00 Mn |
| Dec 31, 2025 | 310.00 Mn |
| Sep 30, 2025 | 303.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 295.00 Mn |
| Dec 31, 2024 | 294.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 249.00 Mn |
| Mar 31, 2024 | 231.00 Mn |
| Dec 31, 2023 | 225.00 Mn |
| Sep 30, 2023 | 212.00 Mn |
| Jun 30, 2023 | 207.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 228.00 Mn |
| Jun 30, 2022 | 222.00 Mn |
| Mar 31, 2022 | 188.00 Mn |
| Dec 31, 2021 | 180.00 Mn |